BVF as of June 30, 2013
Portfolio Holdings for BVF
BVF holds 24 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals In (LGND) | 26.3 | $136M | 3.6M | 37.42 | |
| Chemocentryx | 13.8 | $71M | 5.0M | 14.14 | |
| Ironwood Pharmaceuticals (IRWD) | 10.1 | $52M | 5.3M | 9.95 | |
| Array BioPharma | 9.8 | $51M | 11M | 4.54 | |
| Exelixis Inc cnv | 7.7 | $40M | 41M | 0.97 | |
| Rigel Pharmaceuticals | 6.3 | $33M | 9.7M | 3.34 | |
| Targacept | 5.1 | $26M | 6.2M | 4.27 | |
| Cytokinetics | 3.9 | $20M | 1.7M | 11.57 | |
| Oncothyreon | 2.5 | $13M | 8.1M | 1.56 | |
| Array Biopharma Inc note 3.000% 6/0 | 2.2 | $11M | 12M | 0.95 | |
| Exelixis (EXEL) | 2.2 | $11M | 2.5M | 4.54 | |
| Qlt | 2.0 | $10M | 2.4M | 4.39 | |
| Portola Pharmaceuticals | 1.5 | $7.5M | 306k | 24.57 | |
| Receptos | 1.2 | $6.4M | 320k | 19.89 | |
| ArQule | 1.2 | $6.1M | 2.6M | 2.32 | |
| Pain Therapeutics | 1.0 | $5.2M | 2.4M | 2.21 | |
| AVANIR Pharmaceuticals | 0.9 | $4.6M | 1.0M | 4.60 | |
| Palatin Technologies | 0.6 | $3.1M | 5.2M | 0.60 | |
| Enanta Pharmaceuticals (ENTA) | 0.5 | $2.7M | 154k | 17.71 | |
| Regulus Therapeutics | 0.5 | $2.6M | 266k | 9.81 | |
| Anthera Pharmaceuticals | 0.4 | $2.1M | 4.5M | 0.46 | |
| Flamel Technologies | 0.2 | $931k | 151k | 6.15 | |
| Transcept Pharmaceuticals | 0.1 | $453k | 150k | 3.02 | |
| Genvec | 0.0 | $180k | 486k | 0.37 |
